Covid19
Showing NaN - NaN of 8
Covid19 Trial in Brazil, United States (Remdesivir, Remdesivir Placebo, Aviptadil)
Completed
- Covid19
- Remdesivir
- +4 more
-
Tucson, Arizona
- +39 more
Dec 16, 2022
Cardiovascular Risk Stratification in Covid-19
Completed
- Covid19
- Cardiovascular Risk Factor
-
Portland, OregonOregon Health and Science University
Sep 19, 2022
Covid19 Trial in Bozeman, Mineola, Portland (Hyperbaric Oxygen Therapy (HBOT))
Recruiting
- Covid19
- Hyperbaric Oxygen Therapy (HBOT)
-
Bozeman, Montana
- +2 more
Aug 15, 2022
Covid19 Trial in United States (Apixaban 2.5 MG, Placebo)
Active, not recruiting
- Covid19
- Apixaban 2.5 MG
- Placebo
-
Phoenix, Arizona
- +120 more
Jul 1, 2022
Covid19 Trial in Worldwide (theraputic heparin, prophylactic heparin, P2Y12)
Recruiting
- Covid19
- theraputic heparin
- +4 more
-
Birmingham, Alabama
- +101 more
Jun 28, 2022
ImmuneSense COVID-19 Variant Study
Recruiting
- Covid19
- T-Detect COVID test
-
Phoenix, Arizona
- +14 more
Apr 28, 2022